Conditions: Chronic Lymphocytic Leukemia
Keywords: chronic lymphocytic leukemia maintenance therapy
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 2
Healthy volunteers: no

Brief summary:
This study will determine whether or not Lenalidomide improves effectiveness of treatment for chronic lymphocytic leukemia following chemotherapy with two drugs commonly used to treat the disease (bendamustine and rituximab).

Detailed description:

Arms:
arm 1: Maintenance treatment with lenalidomide following induction treatment with bendamustine and rituximab.

Interventions: intervention 1: Maintenance lenalidomide
Intervention descriptions: intervention 1: Daily maintenance treatment, oral lenalidomide

Protocol document: